federal_register: E7-15372

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
E7-15372 Use of Ozone-Depleting Substances; Removal of Essential-Use Designations; Extension of Comment Period Proposed Rule The Food and Drug Administration (FDA) is extending to September 10, 2007, the comment period for the proposed rule published in the Federal Register of June 11, 2007 (72 FR 32030). The proposed rule would amend FDA's regulation on the use of ozone-depleting substances (ODSs) in self-pressurized containers to remove the essential-use designations for oral pressurized metered-dose inhalers (MDIs) containing flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil. FDA is taking this action in response to a request for an extension. 2007-08-07 2007 8 https://www.federalregister.gov/documents/2007/08/07/E7-15372/use-of-ozone-depleting-substances-removal-of-essential-use-designations-extension-of-comment-period https://www.govinfo.gov/content/pkg/FR-2007-08-07/pdf/E7-15372.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is extending to September 10, 2007, the comment period for the proposed rule published in the Federal Register of June 11, 2007 (72 FR 32030). The proposed rule would amend FDA's regulation on the use of...

Links from other tables